C.R. Bard Inc. announced the Lutonix 035 Drug Coated Balloon PTA Catheter (DCB) has been granted premarket approval (PMA) by the U.S. Food and Drug Administration (FDA) for a new indication. With...
Drug-Eluting Balloons
-
-
The Spectranetics Corp. announced receipt of U.S. Food and Drug Administration (FDA) pre-market approval (PMA) of the Stellarex drug-coated balloon (DCB). The device is designed to restore and...
-
Philips Healthcare and Spectranetics Corp. announced they have entered into a definitive merger agreement for $2.05 billion. The acquisition of Spectranetics will further expand and strengthen...
-
C. R. Bard Inc. announced the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption (IDE) supplemental application to modify the primary endpoint to a six-month time...
News | Drug-Eluting Balloons | September 18, 2017
September 18, 2017 — Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (...
News | Peripheral Artery Disease (PAD) | September 13, 2017
September 13, 2017 — Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual...
News | Drug-Eluting Balloons | September 13, 2017
September 13, 2017 — Medtronic plc announced that the In.Pact Admiral...
Technology | Drug-Eluting Balloons | August 29, 2017
August 29, 2017 — C.R. Bard Inc. announced the Lutonix 035...
News | Drug-Eluting Balloons | August 15, 2017
August 15, 2017 — Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food...
Technology | Drug-Eluting Balloons | July 26, 2017
July 26, 2017 — The Spectranetics Corp. announced receipt of U.S. Food and Drug Administration (FDA) pre-market...
News | June 12, 2017
June 12, 2017 – Med Alliance announced completion on schedule of patient enrollment in the first-in-man (FIM) study...
News | Drug-Eluting Balloons | April 26, 2017
April 26, 2017 — Boston Scientific announced results from the RANGER SFA trial for the Ranger Paclitaxel-Coated PTA...
News | Peripheral Artery Disease (PAD) | March 09, 2017
March 9, 2017 — Medtronic plc announced the launch of the IN.PACT BTK study to evaluate the effectiveness of a...
News | Drug-Eluting Balloons | February 08, 2017
February 8, 2017 — Medtronic plc announced receipt of an investigational device exemption (IDE) from the U.S. Food...
News | Drug-Eluting Balloons | December 06, 2016
December 6, 2016 — The Spectranetics Corp. announced in late November that its Stellarex 0.014-inch...
Technology | Drug-Eluting Balloons | September 26, 2016
September 26, 2016 — C. R. Bard Inc. announced the U.S. Food and Drug Administration (FDA) approved an...
News | Drug-Eluting Balloons | September 22, 2016
September 22, 2016 — New data presented at the Vascular Interventional Advances (VIVA) conference demonstrated the...
Technology | Drug-Eluting Balloons | September 19, 2016
September 19, 2016 — Medtronic plc announced that the U.S. Food and Drug Administration (FDA) approved the IN.PACT...
